Natalizumab in Multiple Sclerosis: Long-Term Management.

Autor: Clerico M; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. marinella.clerico@unito.it., Artusi CA; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. caartusi@gmail.com., Liberto AD; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. ale.dili@hotmail.it., Rolla S; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. simona.rolla@unito.it., Bardina V; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. valentina.bardina87@gmail.com., Barbero P; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. p.barbero@isiline.it., Mercanti SF; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. sdemercanti@yahoo.it., Durelli L; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. luca.durelli@unito.it.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2017 Apr 29; Vol. 18 (5). Date of Electronic Publication: 2017 Apr 29.